“The Role of Caveolae in Cationic Peptide-Based Asymmetric Dendrimer Mediated Cellular Delivery” @ 5th FIP Pharmaceutical Sciences World Congress, Melbourne (Australia) on 13 – 16th April 2014.
“Are caveolae a cellular entry route for peptide based therapeutics delivery systems?” @ NanoBio Australia, Brisbane on 06 – 10th July 2014.
“Targeting of asymmetric amino acid-based cationic dendrimers to caveolae” @ Nanotech France 2015 International Conference & Exhibition, Paris – France on 15 – 17, June 2015.
Caveolin-1 modulates VEGF-A and VEGF-C expression and enhances prostate cancer lymphangiogenesis potential. Nassar, Z.D., M. Francois, R.G. Parton, M-O. Parat. European Society for Medical Oncology (ESMO) Congress, Madrid, Spain, Sep 2014.
The influence of perioperative opioids on cancer metastasis. Xie N., N. Matigian, K.-A. Lê Cao, K. Gregory, T. Vithanage, Z.D. Nassar, P. Cabot, D. Sturgess, P.N. Shaw, M.-O. Parat. Australian Society of Clinical and Experimental Pharmacologists and Toxicologists, Brisbane, Australia, Dec 2017
The role of caveolae in glioblastoma invasiveness. Pu W., Z. Nassar, S. Khabbazi, N. Xie, M.-O. Parat. Australian Society of Clinical and Experimental Pharmacologists and Toxicologists, Brisbane, Australia, Dec 2017
Potential of circulating mu-opioid receptor and toll-like receptor-4 activation in morphine-administered mice. *Xie N., F.P. Gomes, V. Deora, K. Gregory, T. Vithanage, Z.D. Nassar, P.J. Cabot, D. Sturgess, P.N. Shaw, M.O. Parat The International Narcotics Research Conference, Chicago, Jul 2017.
Hypercholesterolemia promotes prostate cancer PC-3 metastases in orthotopic xenograft mice. Moon H., L.J. Sharpe, E. Choi, H. Bielefeldt-Ohmann, Z.D. Nassar, M.O. Parat, M. Francois., C. Soon Lee, A.J. Brown, P.J. Russell, K.L. Inder, M.M. Hill. American Association for Cancer Research Annual Meeting, San Diego, USA, Apr 2014.